Evidence map›Paper›PMID 31481442›Full record

ArticleAntimicrobial agents and chemotherapy2019

Emergence of Plasmodium vivax Resistance to Chloroquine in French Guiana.

Lise Musset, Christophe Heugas, Richard Naldjinan, Denis Blanchet, Pascal Houze, Philippe Abboud, Béatrice Volney, Gaëlle Walter, Yassamine Lazrek, Loïc Epelboin and 5 more

Open access · hybridAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.9field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 39 citations in OpenAlex.

  1. Article
  2. Investigation of Mutations in theMicroorganisms · 2024
    Article
  3. AreBiomedicines · 2024
    Article
  4. Article
  5. Article
  6. Article
  7. The mechanisms of action of Plasmodium infection against cancer.Cell communication and signaling : CCS · 2021
    Review
  8. Short-Time Recurrences ofInternational journal of environmental research and public health · 2021
    Article
  9. Monitoring Plasmodium vivax resistance to antimalarials: Persisting challenges and future directions.International journal for parasitology. Drugs and drug resistance · 2021
    Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 6 institutions in 3 countries.

Lise Musset *Laboratoire de Parasitologie, Centre National de Référence du Paludisme, World Health Organization Collaborating Center for Surveillance of Anti-Malarial Drug Resistance, Institut Pasteur de la Guyane, Cayenne, French Guiana, France lisemusset@gmail.com felix.djossou@ch-cayenne.fr.
Christophe Heugas *Laboratoire de Parasitologie, Centre National de Référence du Paludisme, World Health Organization Collaborating Center for Surveillance of Anti-Malarial Drug Resistance, Institut Pasteur de la Guyane, Cayenne, French Guiana, France.
Richard NaldjinanDepartment of Infectious and Tropical Diseases, Centre Hospitalier Andrée Rosemon, Cayenne, French Guiana, France.
Denis BlanchetLaboratoire Hospitalo-Universitaire de Parasitologie et Mycologie, Centre Hospitalier Andrée Rosemon, Cayenne, French Guiana, France.
Pascal HouzeBiochemistry Laboratory, Hôpital Saint Louis, Paris, France.
Philippe AbboudDepartment of Infectious and Tropical Diseases, Centre Hospitalier Andrée Rosemon, Cayenne, French Guiana, France.
Béatrice VolneyLaboratoire de Parasitologie, Centre National de Référence du Paludisme, World Health Organization Collaborating Center for Surveillance of Anti-Malarial Drug Resistance, Institut Pasteur de la Guyane, Cayenne, French Guiana, France.
Gaëlle WalterDepartment of Infectious and Tropical Diseases, Centre Hospitalier Andrée Rosemon, Cayenne, French Guiana, France.
Yassamine LazrekLaboratoire de Parasitologie, Centre National de Référence du Paludisme, World Health Organization Collaborating Center for Surveillance of Anti-Malarial Drug Resistance, Institut Pasteur de la Guyane, Cayenne, French Guiana, France.
Loïc EpelboinDepartment of Infectious and Tropical Diseases, Centre Hospitalier Andrée Rosemon, Cayenne, French Guiana, France.
Stephane PelleauLaboratoire de Parasitologie, Centre National de Référence du Paludisme, World Health Organization Collaborating Center for Surveillance of Anti-Malarial Drug Resistance, Institut Pasteur de la Guyane, Cayenne, French Guiana, France.
Pascal RingwaldGlobal Malaria Programme, World Health Organization, Geneva, Switzerland.
Eric LegrandMalaria Genetic and Resistance Group, Biology of Host-Parasite Interactions Unit, Institut Pasteur, Paris, France.
Magalie DemarDepartment of Infectious and Tropical Diseases, Centre Hospitalier Andrée Rosemon, Cayenne, French Guiana, France.
Félix DjossouDepartment of Infectious and Tropical Diseases, Centre Hospitalier Andrée Rosemon, Cayenne, French Guiana, France lisemusset@gmail.com felix.djossou@ch-cayenne.fr.
Centre Hospitalier Andrée Rosemon · GFInstitut Pasteur de la Guyane · GFInstitut Pasteur · FRLaboratoire de Biochimie · FRUniversité de Poitiers · FRWorld Health Organization · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In South America,

Indexed as

AdolescentAdultAgedAntimalarialsChildChild, PreschoolChloroquineDrug ResistanceFemaleFrench GuianaHumansMalaria, VivaxMaleMiddle AgedPlasmodium vivaxRetrospective StudiesAntimalarialsChloroquineAmazoniachloroquineFrench GuianaGuiana Shieldpvcrt-oP. vivaxpvmdr1resistance

Identifiers

PMID31481442
PMCPMC6811453
OpenAlexW2970830921

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.